Target intelligence / Profile preview

T-cell receptor beta variable chain (TRBV)

Target
TRBV
Molecular classification
Receptor, Immunoglobulin superfamily
01

Overview

The T-cell receptor (TCR) beta variable (Vβ) chain is a polymorphic protein component of the αβ TCR complex found on the majority of T-lymphocytes. It plays a fundamental role in the adaptive immune system by facilitating the recognition of peptide antigens presented by Major Histocompatibility Complex (MHC) molecules (StatPearls). The diversity of the Vβ repertoire, generated through V(D)J recombination, allows for the detection of a wide range of pathogens and malignant cells (UniProt). In clinical contexts, specific Vβ chains are targeted by bacterial superantigens, such as Toxic Shock Syndrome Toxin-1 (TSST-1), which bypass traditional antigen processing to cause massive, non-specific T-cell activation and systemic inflammation (Nature Reviews Immunology). Therapeutically, monoclonal antibodies directed against specific Vβ families are being investigated to selectively deplete malignant T-cell clones in lymphomas or pathogenic T-cells in autoimmune diseases like multiple sclerosis (Frontiers in Immunology). Monitoring the Vβ repertoire serves as a vital biomarker for assessing immune reconstitution after bone marrow transplantation and for diagnosing T-cell clonality (Journal of Clinical Investigation). However, targeting these chains carries risks, including severe cytokine release syndrome and the potential for broad immunosuppression if multiple Vβ families are affected (Nature Reviews Immunology).

Other names
TCR VβT-cell receptor beta variable regionTRBVV-betaT-cell receptor beta chain variable region
02

Mechanism of action

Binding to the variable region of the T-cell receptor beta chain to induce T-cell activation, depletion, or modulation of specific T-cell subsets.

03

Biological functions

Immune responseAntigen recognitionT-cell activationSignal transduction
04

Disease associations

CancerAutoimmune diseaseInfectionInflammation
05

Safety considerations

Cytokine release syndromeSystemic inflammatory responseOff-target T-cell depletionAutoimmunityImmunosuppression
06

Interacting drugs

Toxic shock syndrome toxin-1 (TSST-1)

3 more in the full profile.

07

Biomarkers

TCR Vβ repertoireTRBV gene rearrangementFlow cytometry Vβ stainingT-cell clonality

Beyond the preview

Go deeper on T-cell receptor beta variable chain (TRBV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor beta variable chain (TRBV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call